Pleural metastases as a unique entity with dismal outcome of head and neck squamous cell carcinomaSHAO, Yu-Yun; HONG, Ruey-Long.Oral oncology (1997). 2010, Vol 46, Num 9, pp 694-697, issn 1368-8375, 4 p.Article

A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinomaHONG, Ruey-Long; TSENG, Yun-Long.Cancer chemotherapy and pharmacology. 2003, Vol 51, Num 5, pp 433-438, issn 0344-5704, 6 p.Article

Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors : The relation between pharmacokinetic property and toxicityHONG, Ruey-Long; TSENG, Yun-Long.Cancer. 2001, Vol 91, Num 9, pp 1826-1833, issn 0008-543XArticle

Fatal Thrombocytopenia after Oxaliplatin-based ChemotherapySHAO, Yu-Yun; HONG, Ruey-Long.Anticancer research. 2008, Vol 28, Num 5B, pp 3115-3117, issn 0250-7005, 3 p.Article

POSTOPERATIVE INTENSITY-MODULATED RADIOTHERAPY FOR SQUAMOUS CELL CARCINOMA OF THE EXTERNAL AUDITORY CANAL AND MIDDLE EAR: TREATMENT OUTCOMES, MARGINAL MISSES, AND PERSPECTIVE ON TARGET DELINEATIONCHEN, Wan-Yu; KUO, Sung-Hsin; KO, Jenq-Yuh et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 4, pp 1485-1493, issn 0360-3016, 9 p.Article

USEFULNESS OF ²⁰¹TI SPECT/CT RELATIVE TO ¹⁸F-FDG PET/CT IN DETECTING RECURRENT SKULL BASE NASOPHARYNGEAL CARCINOMAYEN, Ruoh-Fang; TING, Lai-Lei; CHENG, Mei-Fang et al.Head & neck. 2009, Vol 31, Num 6, pp 717-724, issn 1043-3074, 8 p.Article

Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylateLIN, Ching-Hung; YEN, Roh-Fan; JENG, Yung-Ming et al.Head & neck. 2005, Vol 27, Num 12, pp 1022-1027, issn 1043-3074, 6 p.Article

Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site : Experience with 60 casesHSU, Mow-Ming; HONG, Ruey-Long; TING, Lai-Lei et al.Archives of otolaryngology, head & neck surgery. 2001, Vol 127, Num 7, pp 798-802, issn 0886-4470Conference Paper

Clinicopathological features of salivary and non-salivary adenoid cystic carcinomasLIN, Yu-Chin; CHEN, Ko-Chin; LIN, Ching-Hung et al.International journal of oral and maxillofacial surgery. 2012, Vol 41, Num 3, pp 354-360, issn 0901-5027, 7 p.Article

Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinomaWANG, Chuan-Cheng; CHANG, Jang-Yang; LIU, Tsang-Wu et al.Head & neck. 2006, Vol 28, Num 1, pp 74-80, issn 1043-3074, 7 p.Article

Osteoradionecrosis of the Upper Cervical Spine after Radiation Therapy for Head and Neck Cancer: Differentiation from Recurrent or Metastatic Disease with MR ImagingWU, Li-An; LIU, Hon-Man; WANG, Chun-Wei et al.Radiology. 2012, Vol 264, Num 1, pp 136-145, issn 0033-8419, 10 p.Article

Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: The potential role of quantitative analysis of circulating Epstein-Barr virus DNAHONG, Ruey-Long; LIN, Chin-Yu; TING, Lai-Lei et al.Cancer. 2004, Vol 100, Num 7, pp 1429-1437, issn 0008-543X, 9 p.Article

Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan : implication from age-period-cohort analysisHSU, Chiun; SHEN, Ying-Chun; CHENG, Chia-Chi et al.Cancer epidemiology, biomarkers & prevention. 2006, Vol 15, Num 5, pp 856-861, issn 1055-9965, 6 p.Article

Prognostic value of multidrug resistance 1, glutathione-S-transferase-π and p53 in advanced Nasopharyngeal carcinoma treated with systemic chemotherapyHSU, Chih-Hung; CHEN, Chi-Long; HONG, Ruey-Long et al.Oncology. 2002, Vol 62, Num 4, pp 305-312, issn 0030-2414Article

An International Collaboration to Harmonize the Quantitative Plasma Epstein-Barr Virus DNA Assay for Future Biomarker-Guided Trials in Nasopharyngeal CarcinomaLE, Quynh-Thu; QIANG ZHANG; LEE, Nancy et al.Clinical cancer research (Print). 2013, Vol 19, Num 8, pp 2208-2215, issn 1078-0432, 8 p.Article

Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancerCHUA, Daniel T. T; YIU, Harry Ho-Yin; SZE, Wing-Kin et al.Head & neck. 2012, Vol 34, Num 9, pp 1225-1230, issn 1043-3074, 6 p.Article

Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myelomaHUANG, Shang-Yi; TANG, Jih-Luh; MING YAO et al.Annals of hematology (Print). 2003, Vol 82, Num 9, pp 558-564, issn 0939-5555, 7 p.Article

A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclineHONG, Ruey-Long; LIN, Ching-Hung; CHAO, Tsu-Yi et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 5, pp 847-853, issn 0344-5704, 7 p.Article

Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphomaLI, Chi-Cheng; TIEN, Hwei-Fang; TANG, Jih-Luh et al.Cancer. 2004, Vol 100, Num 2, pp 366-375, issn 0008-543X, 10 p.Article

Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosisWU, Ming-Shiang; LEE, Chung-Wei; SHEU, Jin-Chuan et al.Hepato-gastroenterology. 2002, Vol 49, Num 43, pp 285-289, issn 0172-6390Article

Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthmaLEE, Yueh-Lun; YE, Yi-Ling; YU, Chun-I et al.Human gene therapy. 2001, Vol 12, Num 17, pp 2065-2079, issn 1043-0342Article

Identification of novel mutations of TP53, ALK and RET gene in metastatic thymic squamous cell carcinoma and its therapeutic implicationZHENLI HU; JINGHAN WANG; TONY YAO et al.Lung cancer. 2013, Vol 81, Num 1, pp 27-31, issn 0169-5002, 5 p.Article

Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinomaHONG, Ruey-Long; TING, Lai-Lei; KO, Jenq-Yuh et al.Journal of clinical oncology. 2001, Vol 19, Num 23, pp 4305-4313, issn 0732-183XArticle

Pemetrexed in Combination With Cisplatin Versus Cisplatin Monotherapy in Patients With Recurrent or Metastatic Head and Neck CancerURBA, Susan; VAN HERPEN, Carla M. L; HOSSAIN, Anwar M et al.Cancer. 2012, Vol 118, Num 19, pp 4694-4705, issn 0008-543X, 12 p.Article

Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinomaCHAN, Anthony T. C; HSU, Mow-Ming; MUESER, Matthias et al.Journal of clinical oncology. 2005, Vol 23, Num 15, pp 3568-3576, issn 0732-183X, 9 p.Article